Natera (NTRA) EBITDA Margin (2014 - 2026)
Natera (NTRA) reported EBITDA Margin of 12.21% for Q1 2026, up 110.0% on a YoY basis from 5.81% in Q1 2025, and down 272.15% quarter-over-quarter from 7.09% in Q4 2025.
Natera (NTRA) EBITDA Margin (2014 - 2026) Analysis & Trends
Natera has reported EBITDA Margin for 13 years, with the latest figure at 12.21% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 110.0% year-over-year to 12.21%; the trailing twelve-month figure through Mar 2026 stood at 9.05% (up 121.0% YoY), and the FY2025 full-year result was 9.02%, up 204.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 12.21%, down from 7.09% in the prior quarter.
- The five-year high for EBITDA Margin was 7.09% in Q4 2025, with the low at 77.38% in Q1 2022.
- Historically, EBITDA Margin has averaged 31.28% across 5 years, with a median of 18.48% in 2025.
- Annual changes were most pronounced in 2022 — EBITDA Margin tumbled 3476 bps — and 2023, when it surged 3979 bps.
- Natera's EBITDA Margin stood at 64.13% in 2022, then soared by 62 bps to 24.34% in 2023, then soared by 54 bps to 11.21% in 2024, then soared by 163 bps to 7.09% in 2025, then sank by 272 bps to 12.21% in 2026.
- The last three EBITDA Margin figures came in at 12.21% (Q1 2026), 7.09% (Q4 2025), and 14.77% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -3.71% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 16.93% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 22.58% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 31.78% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 21.74% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 12.38% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -12.21% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 19.16% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 19.42% |
| 10 | Quest Diagnostics | 21.68 Bn | 21.59 Bn | 942.00 Mn | 13.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.21% |
| Dec 31, 2025 | 7.09% |
| Sep 30, 2025 | -14.77% |
| Jun 30, 2025 | -18.48% |
| Mar 31, 2025 | -13.31% |
| Dec 31, 2024 | -11.21% |
| Sep 30, 2024 | -7.05% |
| Jun 30, 2024 | -8.86% |
| Mar 31, 2024 | -18.14% |
| Dec 31, 2023 | -24.34% |
| Sep 30, 2023 | -39.22% |
| Jun 30, 2023 | -41.39% |
| Mar 31, 2023 | -54.75% |
| Dec 31, 2022 | -64.13% |
| Sep 30, 2022 | -59.20% |
| Jun 30, 2022 | -74.49% |
| Mar 31, 2022 | -77.38% |
| Dec 31, 2021 | -83.42% |
| Sep 30, 2021 | -96.27% |
| Jun 30, 2021 | -82.23% |